Literature DB >> 15502120

3T MR imaging: the pros and cons.

Pradip M Pattany.   

Abstract

Mesh:

Year:  2004        PMID: 15502120      PMCID: PMC7976412     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  1 in total

1.  The high-field-strength curmudgeon.

Authors:  Jeffrey S Ross
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

  1 in total
  6 in total

1.  High-resolution 3D-constructive interference in steady-state MR imaging and 3D time-of-flight MR angiography in neurovascular compression: a comparison between 3T and 1.5T.

Authors:  M Garcia; R Naraghi; T Zumbrunn; J Rösch; P Hastreiter; A Dörfler
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-08       Impact factor: 3.825

2.  Advantages and pitfalls in 3T MR brain imaging: a pictorial review.

Authors:  Bernd L Schmitz; Andrik J Aschoff; Martin H K Hoffmann; Georg Grön
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

Review 3.  Proton MR spectroscopy of the brain at 3 T: an update.

Authors:  Alfonso Di Costanzo; Francesca Trojsi; Michela Tosetti; Timo Schirmer; Silke M Lechner; Teresa Popolizio; Tommaso Scarabino
Journal:  Eur Radiol       Date:  2007-01-18       Impact factor: 5.315

4.  High-resolution myocardial perfusion imaging at 3 T: comparison to 1.5 T in healthy volunteers.

Authors:  K Strach; C Meyer; D Thomas; C P Naehle; C Schmitz; H Litt; A Bernstein; B Cheng; H Schild; T Sommer
Journal:  Eur Radiol       Date:  2007-02-16       Impact factor: 5.315

5.  High-resolution myocardial stress perfusion at 3 T in patients with suspected coronary artery disease.

Authors:  Carsten Meyer; Katharina Strach; Daniel Thomas; Harold Litt; Claas P Nähle; Klaus Tiemann; Ulrich Schwenger; Hans H Schild; Torsten Sommer
Journal:  Eur Radiol       Date:  2007-09-13       Impact factor: 5.315

Review 6.  Advances in magnetic resonance neuroimaging.

Authors:  Michael E Moseley; Chunlei Liu; Sandra Rodriguez; Thomas Brosnan
Journal:  Neurol Clin       Date:  2009-02       Impact factor: 3.806

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.